# Far Infrared Therapy on Peritoneal Function of CAPD Patients

Study · id `cardio:ct-nct04344067` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04344067](<https://clinicaltrials.gov/study/NCT04344067>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04344067

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT04344067. Randomized; no masking; primary purpose treatment. Start 2016-01-01 (actual); primary completion 2020-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT04344067, source copy `cardio:ctgov-nct04344067-2020-04-22`, retrieved 2026-10-26)
- Started: 2016-01-01 (actual) (ClinicalTrials.gov record NCT04344067, source copy `cardio:ctgov-nct04344067-2020-04-22`, retrieved 2026-10-26)
- Primary completion: 2020-06-30 (anticipated) (ClinicalTrials.gov record NCT04344067, source copy `cardio:ctgov-nct04344067-2020-04-22`, retrieved 2026-10-26)
- Completion: 2020-06-30 (anticipated) (ClinicalTrials.gov record NCT04344067, source copy `cardio:ctgov-nct04344067-2020-04-22`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT04344067, source copy `cardio:ctgov-nct04344067-2020-04-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04344067-2020-04-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Far Infrared Therapy on Peritoneal Function of CAPD Patients
- Acronym: CAPD
- Condition: End-stage Renal Disease
- Intervention (Device): Far Infrared Therapy
- Lead sponsor: Taipei Veterans General Hospital, Taiwan
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Taipei Veterans General Hospital, Taiwan (`cardio:org-taipei-veterans-general-hospital-taiwan`)

## Provenance

Content hash: 7a7a32fa2b806dbf716211f331a48e6c2fa8db4014222c7c471f2538c1b9b263
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
